共 50 条
- [23] Prognostic ability of the German version of the STarT Back tool: analysis of 12-month follow-up data from a randomized controlled trial BMC Musculoskeletal Disorders, 20
- [24] Cardiovascular Safety of Degarelix: Results From a 12-Month, Comparative, Randomized, Open Label, Parallel Group Phase III Trial in Patients With Prostate Cancer JOURNAL OF UROLOGY, 2010, 184 (06): : 2313 - 2319
- [25] 6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer - A randomized controlled trial JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (07): : 821 - 827
- [27] RANDOMIZED CONTROLLED TRIAL OF A 6-MONTH LOW CARBOHYDRATE INTERVENTION ON WEIGHT AND DISEASE PROGRESSION IN MEN WITH RECURRENT PROSTATE CANCER: CARBOHYDRATE AND PROSTATE STUDY 2 (CAPS2) JOURNAL OF UROLOGY, 2019, 201 (04): : E563 - E563
- [29] Are guided internet-based interventions for the indicated prevention of depression in green professions effective in the long run? Longitudinal analysis of the 6-and 12-month follow-up of a pragmatic randomized controlled trial (PROD-A) INTERNET INTERVENTIONS-THE APPLICATION OF INFORMATION TECHNOLOGY IN MENTAL AND BEHAVIOURAL HEALTH, 2021, 26
- [30] CARDIOVASCULAR SAFETY OF DEGARELIX: RESULTS FROM A 12-MONTH, COMPARATIVE, RANDOMIZED, OPEN-LABEL, PARALLEL-GROUP PHASE III TRIAL IN PROSTATE CANCER PATIENTS JOURNAL OF UROLOGY, 2010, 183 (04): : E228 - E228